Mohamed Abou Shousha

CEO and Founder of Heru, Inc
Associate Professor of Ophthalmology at Bascom Palmer Eye Institute

[Heru, Inc @heruvisionai]

Introducing the FIRST and ONLY wearable device with both dark adaptation and contrast sensitivity, creating a market-leading AMD portfolio. Don’t let AMD be your practice’s blind spot. Learn more at https://t.co/Z0EcTLlxPN.

9 exams. 5 CPT codes. 1 wearable platform.

#HeruDA

[Heru, Inc @heruvisionai]

Introducing the first and only single vision diagnostic health and wellness tool that expands access to care, empowering patients and physicians. Learn more here ➡️ https://t.co/Z0EcTLD8Hl

[Forbes @Forbes]

CEO Mohamed Abou Shousha of @heruvisionai explains how his company's AI-driven vision diagnostic tool to "improve patients' vision and their quality of life" at the #ForbesHealth Summit.

See more: https://t.co/FCJISbnJQs

[Bascom Palmer Eye Institute @BascomPalmerEye]

We are pleased to share that @heruvisionai, the leading Wearable Diagnostic and Vision Augmentation company born at @BascomPalmerEye, has been named a @CES 2022 Innovation Awards Honoree for its re:Vive™ platform developed by a research team led by Dr. Mohamed Abou Shousha

[Guided Solutions @GSMedTech]

Heru’s Wearable Diagnostic, Health and Wellness Platform Honored with Prestigious CES Innovation Award by the Consumer Technology Association (CTA)
https://t.co/cWrrClVBcq
@heruvisionai

[Heru, Inc @heruvisionai]

Thank you @OpportunityFund!

[Heru, Inc @heruvisionai]

#Superherues making magic in the kitchen. 🪄👩‍🍳

#teambuilding #proudtobeasuperheru